ArticleTrials2022

The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19.

Leila Atmowihardjo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.